We use cookies for a better user experience. Read our Privacy Policy

I Agree

Acute Lung Injury Treatment Market

Acute Lung Injury Treatment Market (Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, and Others; and End-user: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Acute Lung Injury Treatment Market Outlook

  • The global industry was valued at US$ 3.0 Bn in 2021
  • It is projected to grow at a CAGR of 3.0% from 2022 to 2031 and reach more than US$ 3.6 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

Rise in alcohol and tobacco consumption among the populace is leading to a surge in cases of lung injuries, which in turn is projected to drive the global acute lung injury treatment market size. Air pollution and obesity can also lead to acute and chronic lung injuries.

Surge in the geriatric population is likely to offer lucrative growth opportunities for vendors in the industry. Vendors are focused on the development, production, and distribution of novel therapies to increase their global acute lung injury treatment market share.

Acute Lung Injury Treatment Market

Market Introduction

Acute Lung Injury (ALI) is a serious medical condition in which lung tissues become inflamed and damaged, resulting in breathing difficulties and low blood oxygen levels. Infections, chemical exposure, and trauma are major factors that can cause ALI. The condition can progress to a more severe disease known as Acute Respiratory Distress Syndrome (ARDS), which has a high mortality rate of around 40% with the current standard of care.

Air pollution is linked to an increased risk of respiratory infections, asthma, and chronic obstructive pulmonary disease (COPD), which can lead to ALI. Elderly people are more susceptible to ALI due to a decline in lung function in the age group. The ongoing COVID-19 pandemic has led to a significant increase in the number of ALI cases, particularly in patients with severe COVID-19 infections.

R&D of New Therapies Augmenting Acute Lung Injury Treatment Market Development

An increase in the incidence of infections, such as influenza and pneumonia, can lead to high cases of ALI. Various studies are exploring the use of biological agents, such as surfactant replacement therapy and anti-inflammatory drugs, for the treatment of ALI.

The development of advanced technologies, such as mechanical ventilation, oxygen therapy, and extracorporeal membrane oxygenation (ECMO), has improved the survival rate of patients with ALI. ECMO is an emerging treatment option for ALI that involves oxygenating the blood outside the body and subsequently returning it to the patient. Thus, R&D of new technologies and a rise in focus on improving patient outcomes are projected to aid in the acute lung injury treatment market growth in the near future.

Rise in Unhealthy Habits among Populace

Smoking is a major risk factor for ALI and COPD. Nicotine present in cigarettes damages the lungs and can lead to inflammation and scarring. This can make it harder for the lungs to function properly, leading to a high risk of ALI and COPD. Thus, the surge in the number of smokers is projected to augment market progress in the next few years.

E-cigarettes and vaping products are gaining traction among the populace. These products have been linked to a rise in cases of ALI. According to the Centers for Disease Control and Prevention (CDC), tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products, particularly from informal sources such as friends, family, or in-person or online dealers, are linked to the majority of E-cigarette or Vaping Use-associated Lung Injury (EVALI) cases. Additionally, in February 2020, the CDC received reports of 2,807 hospitalized cases of EVLAI.

Aerosols produced by e-cigarettes contain various chemicals, including nicotine, flavorings, and solvents, which can be inhaled deep into the lungs. These chemicals can cause irritation and inflammation, leading to ALI symptoms such as shortness of breath, chest pain, and coughing. Moreover, some e-cigarettes have been found to contain harmful substances, such as heavy metals and diacetyl, which can further increase the risk of ALI. Therefore, growth in the usage of e-cigarettes and vaping products is likely to fuel the acute lung injury treatment market statistics in the near future.

A surge in Geriatric Population

Aging leads to a decline in lung function, making older adults more susceptible to ALI. Elderly people witness a decrease in lung elasticity, an increase in inflammation, and a decline in the strength of the immune system. These factors make older adults more susceptible to infections and inflammation.

COPD and heart disease are common diseases in geriatric people. Consumption of multiple medications also increases the risk of ALI in this age group. Therefore, the surge in the geriatric population is expected to augment market dynamics in the next few years.

High Adoption of Mechanical Ventilation

According to the latest acute lung injury treatment market insights, the mechanical ventilation therapy segment is expected to hold the largest share during the forecast period. Mechanical ventilation is the first line of treatment for ALI. It effectively improves oxygenation and reduces the workload of the lungs. Mechanical ventilation can be adjusted to the patient's specific needs and can be utilized in combination with other therapies such as inhaled medications and ECMO.

Increase in Preference for Hospitals

The hospital end-user segment is anticipated to dominate the acute lung injury treatment industry during the forecast period. ALI is a serious medical condition that requires prompt and specialized care, which is typically provided in a hospital setting. Patients generally require a month of hospitalization for the proper treatment and management of ALI.

Hospitals have access to specialized equipment and technologies, such as mechanical ventilators, ECMO machines, and High-frequency Oscillatory Ventilators (HFOV), which are essential for the treatment of ALI. Additionally, hospitals have a team of trained healthcare professionals, including pulmonologists, critical care specialists, and respiratory therapists.

Regional Outlook

According to the latest acute lung injury treatment market forecast, North America is estimated to hold the largest share during the forecast period. An increase in the adoption of vaping and the high prevalence of ALI are expected to propel market revenue in the region in the near future. According to the CDC, about 1 in 20 people in the U.S., several of whom are middle and high school kids, use electronic cigarettes or vapes.

R&D of new therapies for the treatment of ALI is likely to increase the market share in Europe in the next few years. The rise in the geriatric population, growth in air pollution, and surge in cases of ALI and COVID-19 are projected to drive the demand for ALI treatment in Asia Pacific in the near future. A rise in the number of clinical trials and an increase in investment in the R&D of new therapies are estimated to drive the market size in Latin America during the forecast period.

Analysis of Key Players

The global industry is fragmented with the presence of a large number of hospitals. Key players operating in the industry include Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, and Aster Hospitals.

The acute lung injury treatment market research report profiles major vendors based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In December 2022, Peroxitech Inc., a biopharmaceutical firm developing a novel peptide for the treatment of ALI, announced the completion of a US$ 25 Mn Series A fundraising transaction. The funding would be utilized for the development and commercialization of the lead candidate, PIP-2.
  • In April 2020, Chimerix, a biopharmaceutical company that aims to accelerate the process of creating drugs for serious illnesses, commenced a Phase 2/3 study on the use of dociparstat sodium (DSTAT) in COVID-19 patients who have ALI

Global Acute Lung Injury Treatment Market Snapshot

Attribute

Detail

Size in 2021

US$ 3.0 Bn

Forecast Value in 2031

More than US$ 3.6 Bn

CAGR - 2022–2031

3.0%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Therapy
    • Mechanical Ventilation
    • Pharmacotherapy
    • Fluid Management
    • Others
  • End-user
    • Hospitals
    • Specialty Centers
    • Others

.Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Mayo Clinic
  • Johns Hopkins Hospital
  • Cleveland Clinic
  • Great Ormond Street Hospital
  • Apollo Hospitals
  • Tokyo Medical University Hospital
  • The Prince Charles Hospital
  • Helios Hospital
  • Aster Hospitals
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Acute Lung Injury Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global acute lung injury treatment market in 2021?

The global market was valued at US$ 3.0 Bn in 2021.

How big will be the industry size in 2031?

It is projected to reach a value of more than US$ 3.6 Bn by the end of 2031.

What will be the CAGR during the forecast period?

It is anticipated to be 3.0% from 2022 to 2031.

What was the share of the leading segment?

The hospitals segment held more than 60.0% share in 2021.

Which region will account for major share during the forecast period?

North America is expected to account for largest share from 2022 to 2031.

Who are the prominent players operating in the market?

Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, and Aster Hospitals.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Acute Lung Injury Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Acute Lung Injury Treatment Market Analysis and Forecast, 2017 - 2031

        4.4.1. Market Revenue Projection (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario by Region/Globally

    5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)

    5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Therapy

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Therapy, 2017 - 2031

        6.3.1. Mechanical Ventilation

        6.3.2. Pharmacotherapy

        6.3.3. Fluid Management

        6.3.4. Others

    6.4. Market Attractiveness, by Therapy

7. Global Acute Lung Injury Treatment Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by End-user, 2017 - 2031

        7.3.1. Hospitals

        7.3.2. Specialty Centers

        7.3.3. Others

    7.4. Market Attractiveness, by End-user

8. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness, by Country/Region

9. North America Acute Lung Injury Treatment Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Therapy, 2017 - 2031

        9.2.1. Mechanical Ventilation

        9.2.2. Pharmacotherapy

        9.2.3. Fluid Management

        9.2.4. Others

    9.3. Market Value Forecast, by End-user, 2017 - 2031

        9.3.1. Hospitals

        9.3.2. Specialty Centers

        9.3.3. Others

    9.4. Market Value Forecast, by Country, 2017 - 2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Therapy

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Acute Lung Injury Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Therapy, 2017 - 2031

        10.2.1. Mechanical Ventilation

        10.2.2. Pharmacotherapy

        10.2.3. Fluid Management

        10.2.4. Others

    10.3. Market Value Forecast, by End-user, 2017 - 2031

        10.3.1. Hospitals

        10.3.2. Specialty Centers

        10.3.3. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Therapy

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Acute Lung Injury Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Therapy, 2017 - 2031

        11.2.1. Mechanical Ventilation

        11.2.2. Pharmacotherapy

        11.2.3. Fluid Management

        11.2.4. Others

    11.3. Market Value Forecast, by End-user, 2017 - 2031

        11.3.1. Hospitals

        11.3.2. Specialty Centers

        11.3.3. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Therapy

        11.5.2. By End-user

        11.5.3. By Country/sub-region

12. Latin America Acute Lung Injury Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Therapy, 2017 - 2031

        12.2.1. Mechanical Ventilation

        12.2.2. Pharmacotherapy

        12.2.3. Fluid Management

        12.2.4. Others

    12.3. Market Value Forecast, by End-user, 2017 - 2031

        12.3.1. Hospitals

        12.3.2. Specialty Centers

        12.3.3. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Therapy

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Acute Lung Injury Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Therapy, 2017 - 2031

        13.2.1. Mechanical Ventilation

        13.2.2. Pharmacotherapy

        13.2.3. Fluid Management

        13.2.4. Others

    13.3. Market Value Forecast, by End-user, 2017 - 2031

        13.3.1. Hospitals

        13.3.2. Specialty Centers

        13.3.3. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Therapy

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of Companies)

    14.2. Market Share Analysis By Company (2021)

    14.3. Company Profiles

        14.3.1. Mayo Clinic

            14.3.1.1. Company Overview

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. Business Strategies

            14.3.1.5. Recent Developments

        14.3.2. Johns Hopkins Hospital

            14.3.2.1. Company Overview

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. Business Strategies

            14.3.2.5. Recent Developments

        14.3.3. Cleveland Clinic

            14.3.3.1. Company Overview

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. Business Strategies

            14.3.3.5. Recent Developments

        14.3.4. Great Ormond Street Hospital

            14.3.4.1. Company Overview

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. Business Strategies

            14.3.4.5. Recent Developments

        14.3.5. Apollo Hospitals

            14.3.5.1. Company Overview

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. Business Strategies

            14.3.5.5. Recent Developments

        14.3.6. Tokyo Medical University Hospital

            14.3.6.1. Company Overview

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. Business Strategies

            14.3.6.5. Recent Developments

        14.3.7. The Prince Charles Hospital

            14.3.7.1. Company Overview

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. Business Strategies

            14.3.7.5. Recent Developments

        14.3.8. Helios Hospital

            14.3.8.1. Company Overview

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. Business Strategies

            14.3.8.5. Recent Developments

        14.3.9. Aster Hospitals

            14.3.9.1. Company Overview

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. Business Strategies

            14.3.9.5. Recent Developments

List of Tables

Table 01: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031

Table 02: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 03: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031

Table 06: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 07: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 08: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031

Table 09: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 10: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031

Table 12: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 13: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031

Table 15: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 16: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017‒2031

Table 18: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

List of Figures

Figure 01: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Acute Lung Injury Treatment Market Value Share, by Therapy, 2021

Figure 04: Acute Lung Injury Treatment Market Value Share, by End-user, 2021

Figure 05: Acute Lung Injury Treatment Market Value Share, by Region, 2021

Figure 06: Global Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 07: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 08: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Mechanical Ventilation, 2017‒2031

Figure 09: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Pharmacotherapy, 2017‒2031

Figure 10: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Fluid Management, 2017‒2031

Figure 12: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Others, 2017‒2031

Figure 13: Global Acute Lung Injury Treatment Market Value Share Analysis, by End-user 2021 and 2031

Figure 14: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user 2022–2031

Figure 15: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 16: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Specialty Centers, 2017–2031

Figure 17: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Others, 2017–2031

Figure 18: Global Acute Lung Injury Treatment Market Value Share Analysis, by Region, 2021 and 2031

Figure 19: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by Region, 2022–2031

Figure 20: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 21: North America Acute Lung Injury Treatment Market Value Share Analysis, by Country, 2021 and 2031

Figure 22: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by Country, 2022–2031

Figure 23: North America Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 24: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy 2022–2031

Figure 25: North America Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031

Figure 26: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 27: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 28: Europe Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 29: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 30: Europe Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 31: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 32: Europe Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031

Figure 33: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 34: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 35: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 36: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 37: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 38: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 39: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031

Figure 40: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 41: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 42: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 43: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 44: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 45: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 46: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031

Figure 47: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 48: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 49: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 50: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 51: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 52: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 53: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031

Figure 54: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 55: Company Share Analysis

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

871

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved